After many lean years, important progress has been made in updating the anti-tuberculosis drug armamentarium; a new drug that targets bacterial protein synthesis is one of several that could help transform the treatment of this neglected and deadly disease.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chaisson, R. E., Frick, M. & Nahid, P. Int. J. Tuberc. Lung Dis. 26, 186–189 (2022).
Dorman, S. E. et al. N. Engl. J. Med. 384, 1705–1718 (2021).
Diacon, A. H. et al. Nat. Med. https://doi.org/10.1038/s41591-024-02829-7 (2024).
Conradie, F. et al. N. Engl. J. Med. 382, 893–902 (2020).
Gler, M. T. et al. N. Engl. J. Med. 366, 2151–2160 (2012).
Conradie, F. et al. N. Engl. J. Med. 387, 810–823 (2022).
Li, X. et al. J. Med. Chem. 60, 8011–8026 (2017).
Dawson, R. et al. Antimicrob. Agents Chemother. 67, e0147722 (2023).
Gupta, A. et al. Clin. Infect. Dis. 62, 761–769 (2016).
Nogueira, B. M. F. et al. EMBO Mol. Med. 14, e14088 (2022).
Xie, Y. L. et al. Sci. Transl. Med. 13, eabd7618 (2021).
Ma, Z., Lienhardt, C., McIlleron, H., Nunn, A. J. & Wang, X. Lancet 375, 2100–2109 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Nuermberger, E.L., Chaisson, R.E. Restocking the tuberculosis drug arsenal. Nat Med 30, 642–643 (2024). https://doi.org/10.1038/s41591-024-02840-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-024-02840-y
